Damage to a person’s spinal cord doesn’t stop at the time of injury: the cord can continue to deteriorate for a long time afterwards, for reasons that are still not yet fully understood. This is why research into the cure for spinal cord injuries looks not only at how to repair the initial injury, but also how to prevent this delayed deterioration of the spinal cord after injury has occurred. This second type of research is known as “neuroprotective” research. The work of a team of Alberta researchers into one potential neuroprotective agent, minocycline, has led to an international collaboration to translate this promising therapy to clinical practice.